Home / Business and Economy / Fundly.ai Raises $4.9M to Revolutionize Pharma Supply Chain
Fundly.ai Raises $4.9M to Revolutionize Pharma Supply Chain
8 Sep
Summary
- Fundly.ai secured $4 million in equity and $0.9 million in venture debt.
- The company expanded into B2B commerce, payments, and embedded credit.
- Fundly.ai was founded in 2021 as a supply-chain finance platform.
Mumbai-based Fundly.ai, a burgeoning B2B pharmaceutical distribution platform, has announced a significant funding round, securing $4 million in equity investment. This round was led by existing investors Accel and Multiply, with additional venture debt totaling $0.9 million. The infusion of capital is earmarked for expanding Fundly.ai's digital commerce, payment infrastructure, and embedded credit services across India's vast pharmaceutical supply chain.
Established in 2021, Fundly.ai initially focused on supply-chain finance for pharmaceutical companies. It has since evolved into a multifaceted business encompassing B2B commerce, transaction and settlement infrastructure, and embedded credit solutions. This strategic pivot aims to streamline and digitize critical aspects of the pharma industry.
